Gabapentin cost analysis
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin Cost-Effectiveness in Neuropathic Pain Management
Gabapentin is widely used for neuropathic pain, but its cost-effectiveness varies depending on the condition and comparison with other drugs. In stroke patients with neuropathic pain, gabapentin was found to be more cost-effective than amitriptyline, with a higher incremental net benefit, despite a slightly higher average cost-effectiveness ratio (ACER) compared to amitriptyline. The analysis concluded that gabapentin provided better value for money in this patient group .
Gabapentin vs. Pregabalin: Cost and Outcomes
Several studies have compared gabapentin with pregabalin for neuropathic pain conditions such as diabetic polyneuropathy and post-herpetic neuralgia. In Spain, generic gabapentin had lower total health costs than branded pregabalin, but pregabalin provided more days with mild or no pain and a small gain in quality-adjusted life years (QALYs). The incremental cost-effectiveness ratio (ICER) for pregabalin was moderate, suggesting that while pregabalin is more effective, it comes at a higher cost . Similar findings were observed in China, where pregabalin led to better pain outcomes but at increased cost compared to gabapentin . Another real-world study found that pregabalin had lower overall healthcare and non-healthcare costs than gabapentin, mainly due to reduced use of additional analgesics and fewer healthcare visits . However, a cost-consequences analysis in primary care showed that while pregabalin reduced pain more than gabapentin, the overall cost reduction was similar between the two drugs . A Swedish analysis also indicated that pregabalin could be cost-saving from a societal perspective, mainly due to better health outcomes and reduced indirect costs .
Gabapentin Cost in Migraine and Osteoarthritis
In migraine management, gabapentin was the most expensive among the commonly used antiepileptic drugs, with a higher cost-equivalent number. Divalproex sodium was found to be the most cost-effective option, making gabapentin less favorable from a cost perspective in this setting . For knee osteoarthritis, adding gabapentin to usual care did not provide good value, as it increased costs and reduced QALYs compared to standard care alone .
Gabapentin Dosage and Hospital Costs
Higher preoperative doses of gabapentin were associated with longer stays in the post-anesthesia care unit (PACU), leading to increased hospital costs. For every 1 mg/kg increase in gabapentin dosage, PACU length of stay increased by about 7 minutes, resulting in significant additional monthly costs for hospitals .
Gabapentin Compared to Other Treatments
When compared to lidocaine 5% medicated plaster and pregabalin for postherpetic neuralgia, gabapentin was included as a comparator in cost-effectiveness analyses, but specific cost outcomes were not detailed in the available summary .
Conclusion
Gabapentin's cost-effectiveness varies by condition and comparator. It is more cost-effective than amitriptyline for neuropathic pain after stroke, but less cost-effective than divalproex sodium for migraine. Compared to pregabalin, gabapentin generally has lower direct drug costs but may result in higher overall healthcare costs due to less effective pain control and increased resource use. In some real-world settings, pregabalin may be more cost-effective or even cost-saving when considering both direct and indirect costs. Higher gabapentin dosages can also increase hospital costs due to longer recovery times. Overall, gabapentin remains a viable and sometimes cost-effective option, but its value depends on the specific clinical context and available alternatives Pratiwi2020Rodríguez2007Bensen2022+7 MORE.
Sources and full results
Most relevant research papers on this topic